scholarly journals Time course of post-operative pain and plasma levels after single administration of Voltaren Suppo.

Ensho ◽  
1987 ◽  
Vol 7 (3) ◽  
pp. 289-292
Author(s):  
TAKEHIKO TORISU
Keyword(s):  
Plasma Levels ◽  
Time Course ◽  
Single Administration ◽  
Post Operative Pain

A Novel Chimaeric Derivative of Saruplase, rscu-PA-40kDA/Hir, Binds to Thrombin and Exerts Thrombus-specific Fibrinolysis in Arterial and Venous Thrombosis in Dogs

1997 ◽  
Vol 77 (03) ◽  
pp. 535-539 ◽  
Author(s):  
J Schneider ◽  
R Hauser ◽  
H-H Hennies ◽  
J Korioth ◽  
G Steffens ◽  
...  
Keyword(s):  
Venous Thrombosis ◽  
Plasma Levels ◽  
Time Course ◽  
Bolus Injection ◽  
Specific Activity ◽  
Intravenous Bolus ◽  
Protease Domain ◽  
Parent Molecule ◽  
Significant Prolongation ◽  
Inhibitory Domain

SummaryThe chimaeric molecule rscu-PA-40kDA/Hir (M23) comprises the kringle and protease domain of saruplase (rscu-PA) and a thrombin inhibitory domain fused to the C-terminus of the protease domain. The 27 amino acid long thrombin inhibitory domain contains a sequence directed to the active site of thrombin and a fragment from the C-terminal region of hirudin. 125I-radiolabelled M23 (0.03 µM) bound to thrombin that was immobilised onto CNBr-activated sepharose beads. Unlabelled M23 (0.01-10 |xM) and hirudin (0.001-10 µµM) concentra-tion-dependently displaced 125I-M23 from its binding to thrombin. Saruplase (up to 10 (iM) did not influence the thrombin binding of M23. The fibrinolytic properties of M23 and saruplase were compared in anaesthetized dogs with femoral artery and saphenous vein thrombosis. Under concomitant heparinization, the intravenous bolus injections of 1 mg/kg M23 or saruplase induced reperfusion of thrombotically occluded femoral arteries in 4 out of 5 treated animals in each case. There was one reocclusion in the M23-treated group. Time to reperfusion (23 ± 4 vs 25 ± 11 min) and maximal height of reperfusion blood flow (98 ± 21 vs 108 ± 15 % of baseline flow) did not differ significantly between the treatment groups. The time course of the lysis of incorporated 125I-fibrin radioactivity in thrombosed saphenous veins was similar after bolus injections of M23 and saruplase. The maximal dissolution of 125I-fibrin in the venous thrombosis model was 91 ± 1 % in M23-and 88 ± 5 % in saruplase-treated animals. Plasma levels of fibrinogen were not influenced and a2-antiplasmin levels were slightly reduced (-27 ± 3 %) after bolus injection of M23. In contrast, bolus injection of saruplase was accompanied by a significant decrease of fibrinogen (-55 ± 19 %) and a2-antiplasmin (-75 ±11%) plasma levels. Template bleeding times virtually did not differ before (2.8 ± 0.3 min) and 60 min after bolus injection of M23 (3.1 ± 0.3 min), whereas treatment with saruplase resulted in a significant prolongation of template bleeding time from 2.6 ± 0.2 min to 28 ± 13 min. It is concluded that the saruplase derivative M23, while inducing equieffective thrombolysis after intravenous bolus injection in dogs, causes much fewer haemostatic side effects than its parent molecule. The high thrombus-specific activity of M23 is tentatively attributed to its affinity to clot-bound thrombin.

Effects of acute and chronic treatment with glucocorticoids on the intestinal absorption of calcium and phosphate and on plasma 1,25-dihydroxyvitamin D levels in pigs

1985 ◽  
Vol 69 (5) ◽  
pp. 553-559 ◽  
Author(s):  
John Fox ◽  
Richardus Ross ◽  
Anthony D. Care
Keyword(s):  
Intestinal Absorption ◽  
Plasma Levels ◽  
Time Course ◽  
Chronic Treatment ◽  
Intestinal Loop ◽  
Phosphate Absorption ◽  
Dihydroxyvitamin D ◽  
1,25 Dihydroxyvitamin D ◽  
Young Pigs ◽  
Proximal Small Intestine

1. We have used young pigs, each prepared surgically with a Thiry-Vella loop of proximal small intestine, to study the time course of changes in the intestinal absorption of calcium, phosphate, sodium, glucose and water and on the plasma levels of 1,25-dihydroxyvitamin D after treatment of the animals with glucocorticoids. 2. Perfusion of the intestinal loop for 6 h with a solution containing hydrocortisone or betamethasone was without effect on the absorption of calcium or phosphate. 3. The oral administration of betamethasone stimulated the absorption of calcium and phosphate by 15–20% for 2–3 days before the trend was reversed and absorption was progressively reduced. 4. Chronic treatment with betamethasone inhibited only the active component of calcium and phosphate absorption. 5. Treatment with betamethasone was associated with a sustained 25–50% increase, to a maximum by 2 days, in the absorption of sodium, glucose and water. 6. Plasma levels of 1,25-dihydroxyvitamin D were reduced within 2 days of the start of treatment and reached a minimum (40–50% decrease) in 4–6 days. 7. We conclude that the initial stimulation of calcium and phosphate absorption is caused by the increased absorption of water. The long-term decrease in absorption may not be caused solely by the decreased circulating levels of 1,25-dihydroxyvitamin D since absorption continued to fall for several weeks after 1,25-dihydroxyvitamin D levels had reached a minimum.

PHOTOPERIODIC MODULATION OF GONADOTROPHIN SECRETION IN CASTRATED JAPANESE QUAIL

1982 ◽  
Vol 92 (1) ◽  
pp. 73-83 ◽  
Author(s):  
H. F. URBANSKI ◽  
B. K. FOLLETT
Keyword(s):  
Japanese Quail ◽  
Plasma Levels ◽  
Time Course ◽  
Neural Mechanisms ◽  
Gonadal Steroids ◽  
Photoperiodic Control ◽  
Gonadotrophin Secretion ◽  
Lh Secretion ◽  
Sexually Mature ◽  
Short Days

Male Japanese quail were castrated when sexually immature and immediately exposed to one of the following stimulatory lighting regimes for 52 days: 11 h light: 13 h darkness/day (11L : 13D), 12L : 12D, 13L : 11D, 14L : 10D, 15L : 9D, 16L : 8D, 20L : 4D or 23L : 1D. One group was retained on short days (8L : 16D). Clearcut differences in the plasma levels of LH and FSH emerged between the various groups. Levels remained very low in castrated quail on 8L : 16D but were much greater in those on 14L : 10D, 15L : 9D, 16L : 8D, 20L : 4D and 23L : 1D, eventually becoming 15 to 20 times higher. Less pronounced castration responses developed on 13L : 11D, 12L : 12D or 11L : 13D. Alterations in photoperiod after day 52 caused an appropriate rise or fall in LH secretion. Photoperiodically induced suppressions were rapid, being highly significant within 4 days, but increases usually had a slower time course. When sexually mature quail (on 16L : 8D) were castrated and transferred to 8L : 16D they also exhibited a rapid suppression in LH secretion. Thus in quail, unlike some mammals, the photoperiodic control over gonadotrophin secretion is independent of the reproductive status of the animal at the time of castration. The results confirm the view that changes in sensitivity of the hypothalamo-pituitary axis to gonadal steroids are not a primary factor in the neural mechanisms underlying photoperiodism in quail.

DOSE REGIMENS OF HUMAN GROWTH HORMONE: EFFECTS OF CONTINUOUS INFUSION AND OF A GELATIN VEHICLE ON GROWTH IN RATS AND RATE OF ABSORPTION IN RABBITS

1980 ◽  
Vol 87 (2) ◽  
pp. 303-312 ◽  
Author(s):  
P. MARY COTES ◽  
W. A. BARTLETT ◽  
ROSE E. GAINES DAS ◽  
P. FLECKNELL ◽  
R. TERMEER
Keyword(s):  
Growth Hormone ◽  
Human Growth Hormone ◽  
Plasma Levels ◽  
Time Course ◽  
Human Growth ◽  
Daily Injection ◽  
Glycine Buffer ◽  
Hormone Effects ◽  
Rate Of Absorption ◽  
Hypophysectomized Rats

Different methods for administration of human growth hormone (hGH) have been examined with a view to efficient use of the limited amounts of hGH at present available for clinical use. We found that in hypophysectomized rats (1) hGH administered by continuous subcutaneous infusion induced a greater increase in body weight (referred to throughout as growth) than hGH administered by intermittent (daily) injection and (2) intermittent injections of hGH dissolved in 16% gelatin induced more growth than hGH dissolved in a glycine buffer. It was further found that (1) hGH dissolved in 16% gelatin compared with hGH dissolved in a glycine buffer induced lower maximal levels of immunoreactive plasma hGH and between 7 and 9 h after treatment higher plasma levels when injected subcutaneously in rabbits, (2) 125I-labelled hGH added as a tracer to hGH in gelatin was removed more slowly from subcutaneous injection sites in rabbits than 125I-labelled hGH given with hGH in glycine buffer and (3) changes in the ratio of hGH to gelatin had little effect on the time-course of plasma levels of hGH in the rabbit. Addition of the protease inhibitors aprotinin or 6-aminohexanoic acid, to injection of hGH in gelatin or glycine did not induce any consistent increase in plasma levels of hGH.

Time Course of Plasma Levels and Electrophysiologic Effects of Propranolol in Man

1980 ◽  
Vol 2 (6) ◽  
pp. 707-714 ◽  
Author(s):  
E. Riva ◽  
R. Latini ◽  
A. Cremonesi ◽  
F. Zacà ◽  
P. Pagliarani
Keyword(s):  
Plasma Levels ◽  
Time Course

Relationship between biomarkers and everolimus efficacy in the phase III RECORD-1 trial of patients with metastatic renal cell carcinoma (mRCC).

2013 ◽  
Vol 31 (6_suppl) ◽  
pp. 352-352
Author(s):  
Stephane Oudard ◽  
Bernard J. Escudier ◽  
John A. Thompson ◽  
Viktor Grünwald ◽  
Cristina Masini ◽  
...  
Keyword(s):  
Plasma Levels ◽  
Time Course ◽  
Proportional Hazards ◽  
Proportional Hazards Model ◽  
Day Treatment ◽  
Cox Proportional Hazards ◽  
Cox Proportional Hazards Model ◽  
Phase Iii ◽  
Continuous Variables ◽  
Baseline Levels

352 Background: Compared with placebo, everolimus provided significant improvement in median PFS in the RECORD-1 study of VEGFr-TKI-refractory mRCC. To investigate the role of angiogenesis pathway molecules as potential biomarkers of everolimus efficacy in RECORD-1, plasma levels of sVEGFR-2, VEGF-A, and bFGF were estimated. Methods: In addition to best supportive care, patients received everolimus 10 mg/day (n = 277) or placebo (n = 139). Placebo patients who progressed were offered everolimus. Predose blood samples were collected on day 1 of the first four 28-day treatment cycles. Plasma levels of sVEGFR-2, VEGF-A, and bFGF were assessed by ELISA. Effect of treatment over time on each biomarker was assessed by a mixed effects model. Hazard ratios (HR) for prognostic effects were obtained using log baseline biomarker values as continuous variables in a stratified Cox proportional hazards model. Results: Plasma levels of sVEGFR-2, VEGF-A, and bFGF were available for 45%, 45%, and 39% of everolimus patients and 50%, 50%, and 45% of placebo patients. Patients with biomarker data had baseline characteristics similar to those of the overall population. Mean baseline levels (pg/mL) of sVEGFR-2, VEGF-A, and bFGF were similar for everolimus (8945, 245, and 8, respectively) and placebo (8985, 253, and 13, respectively). Everolimus significantly improved median PFS over placebo irrespective of baseline levels of the analyzed biomarkers (p < 0.001), indicating they are not predictive of everolimus efficacy. Prolonged PFS in the biomarker population was associated with lower VEGF-A baseline level (HR, 1.27; 95% CI, 1.03-1.57; p = 0.028), suggesting VEGF-A may be prognostic for mRCC. Compared with placebo, everolimus significantly reduced bFGF (p = 0.0095) and sVEGFR-2 (p< 0.001) levels over the time course of the study; no effect on VEGF-A levels was observed. Conclusions: Everolimus significantly improved PFS compared with placebo, regardless of baseline biomarker levels. Lower VEGF-A levels may be a potential prognostic factor for longer PFS. Everolimus treatment significantly downregulated plasma levels of bFGF and sVEGFR-2 from baseline. Clinical trial information: NCT00410124.

Abstract 462: Effect of Coronary Revascularization on Plasma Level of Asymmetric Dimethylarginine

2014 ◽  
Vol 34 (suppl_1) ◽  
Author(s):  
Adam Nemeth ◽  
Zsofia Lenkey ◽  
Zeno Ajtay ◽  
Attila Cziraki ◽  
Endre Sulyok ◽  
...  
Keyword(s):  
Coronary Sinus ◽  
Plasma Levels ◽  
Time Course ◽  
Asymmetric Dimethylarginine ◽  
Coronary Revascularization ◽  
Artery Bypass ◽  
Bypass Graft ◽  
Cabg Surgery ◽  
Off Pump ◽  
Group I

Background: Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide synthase. Increased ADMA plasma levels are associated with atherosclerosis and cardiovascular disease. In this study we investigated the plasma levels of ADMA in patients who underwent different type of coronary revascularization. Methods: Concentrations of ADMA, l-arginine, symmetric dimethylarginine (SDMA) were measured by liquid chromatography-tandem mass spectrometry in four groups: group I consisted of 16 patients with ST-elevation myocardial infarction (STEMI), and group II included 24 patients who underwent elective percutaneous coronary intervention (PCI). Before PCI and at 1 hour, 5 days and 30 days after reperfusion blood samples were taken for measurement of l-arginine, ADMA and SDMA. Group III consisted of 21 patients undergoing off-pump and group IV included 20 patients undergoing on-pump coronary artery bypass graft (CABG) surgery. The measurements were performed 24 h before, 3 times during the operation (via coronary sinus catheter), and on the 1st and 5th postoperative day. Results: In patients with elective stent implantation stenting induced a prompt and sustained depression of ADMA (F=9.594, p<0.001), however ADMA remained constant for STEMI patients after stent placement (F=2.982, p=0.069). The differences in the time-course for ADMA (F=9.431, p<0.001) proved to be significant between the two groups. We did not find significant change in the plasma concentration of ADMA during off-pump CABG surgery (F=0.416, p=0.68), however ADMA concentration increased significantly in patients who underwent on-pump surgery both in the coronary sinus (F=14.751, p<0.001) and peripheral blood (F=30.738, p<0.001). Therefore, the intersubject time effect, was significant (F=6.990, p=0.002). Conclusions: The main finding of the present study is that the response pattern of the new cardiovascular risk factor, ADMA was significantly different between the two PCI and the CABG groups. Its long-term follow-up may be suitable to monitor the improvement of coronary function after revascularisation. This method should be feasible to monitor of the ADMA metabolism during coronary revascularization.

Time course of frontal somatosensory evoked potentials: Relation to L-dopa plasma levels and motor performance in PD

Neurology ◽  
1999 ◽  
Vol 53 (7) ◽  
pp. 1451-1451 ◽  
Author(s):  
M. Ulivelli ◽  
S. Rossi ◽  
P. Pasqualetti ◽  
P. M. Rossini ◽  
O. Ghiglieri ◽  
...  
Keyword(s):  
Evoked Potentials ◽  
Somatosensory Evoked Potentials ◽  
Plasma Levels ◽  
Motor Performance ◽  
Time Course
Sign in / Sign up

Export Citation Format

Share Document